Human In Vivo Clinical Trials
Products that are accepted for Human In Vivo Clinical Trials are limited to orally ingested foods, beverages, Nutraceutical, and Pharmaceuticals.
Products that are accepted into the Clinical Testing Program will undergo Board Approved Human In Vivo Clinical Trials.
Test Foods (products submitted) that pass the clinical protocols qualify to display the Glycemic Research Institute® Government Certification Marks on products labels and brochures, and to make specific claims. All Clinical Trials are based on FDA CFR21 Guidelines.
Companies may submit products that are in development, in the R & D stage, and/or products that are already on the market.
A Clinical Studies Coordinator will be assigned to work one-on-one with the client.
Products-in-development can be analyzed for their glycemic, diabetic, fat-storing, and/or Kid-Friendly properties, depending on the client needs. These trials are “Investigational” and help assist companies develop Low Glycemic products that address specific health issues, such as obesity, diabetes, and the current childhood obesity epidemic.
Following the Investigational Trials, the client will receive a full report on the results of the trial, and may request a phone conference with the Medical Advisory Board to discuss results of the trials and directional advice on options for reformulating the Test Food.
PROGRAMS, SERVICES & CLIENT OPTIONS
The Glycemic Research Institute®
offers the following Programs:
BOARD CERTIFIFED HUMAN IN VIVO CLINICAL TRIAL
GOVERNMENT CERTIFICATION PROGRAMS:
UNITED STATES GOVERNMENT CERTIFICATION PROGRAM
UNITED KINGDOM GOVERNMENT CERTIFICATION PROGRAM
CANADIAN GOVERNMENT CERTIFICATION PROGRAM
CLINICAL STUDIES: INVESTIGATIONAL TRIALS
FDA & FTC CLAIM SUBSTANTIATION